Trial intelligence / Profile preview

L-thyroxine plus liothyronine vs L-thyroxine alone in post-surgical hypothyroidism

KCT0002600Phase 4Recruiting

Sponsor
Dalim Biotech
Start
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levothyroxine sodium, liothyronine in hypothyroidism, thyroid neoplasm, sponsored by Dalim Biotech. Started Apr 2018; status: recruiting.

02

Drugs

levothyroxine sodiumliothyronine
03

Conditions

hypothyroidismthyroid neoplasm

Beyond the preview

Go deeper on KCT0002600.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0002600.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call